The popularity of medicinal cannabis is increasing the potential risk of hazardous pharmacokinetic interactions with commonly used anti-rheumatic drugs, rheumatologists have been told. Many clinicians and patients may not appreciate that the cannabinoids used in management of chronic pain and musculoskeletal conditions may potentiate the effects of analgesics and anti-inflammatory drugs through an interaction with ...
Warning on medicinal cannabis interactions with rheumatology drugs
By Michael Woodhead
19 Aug 2020